Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy
Rajshekhar Chakraborty(Columbia University Irving Medical Center), Eli Muchtar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Anannya Patwari(Medical College of Wisconsin), Shaji Kumar(Mayo Clinic), Suzanne Lentzsch(Columbia University Irving Medical Center), Anita D’Souza, Geethika Bodanapu(Boston University), Stefan Schönland(Heidelberg University), Saurabh Zanwar(Mayo Clinic), Ute Hegenbart(Heidelberg University), Giovanni Palladini(University of Pavia), Paolo Milani(University of Pavia), Andrew J. Cowan(University of Washington), Divaya Bhutani(Columbia University Irving Medical Center), Angela Dispenzieri(Mayo Clinic), GuiZhen Chen(University of Washington), Vaishali Sanchorawala(Boston Medical Center)
Cited by 18
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k